91Ó°ÊÓ

Decision errors in medical diagnostic testing Consider medical diagnostic testing, such as using a mammogram to detect if a woman may have breast cancer. Define the null hypothesis of no effect as the patient does not have the disease. Define rejecting \(\mathrm{H}_{0}\) as concluding that the patient has the disease. See the table for a summary of the possible outcomes: $$ \begin{array}{lll} \hline & \text { Medical Diagnostic Testing } & \\ \hline & {\text { Medical Diagnosis }} \\ \hline \text { Disease } & \text { Negative } & \text { Positive } \\ \hline \text { No }\left(\mathrm{H}_{0}\right) & \text { Correct } & \text { Type I error } \\ \text { Yes }\left(\mathrm{H}_{a}\right) & \text { Type II error } & \text { Correct } \\ \hline \end{array} $$ a. When a radiologist interprets a mammogram, explain why a Type I error is a false positive, predicting that a woman has breast cancer when actually she does not. b. A Type II error is a false negative. What does this mean, and what is the consequence of such an error to the woman? c. A radiologist wants to decrease the chance of telling a woman that she may have breast cancer when actually she does not. Consequently, a positive test result will be reported only when there is extremely strong evidence that breast cancer is present. What is the disadvantage of this approach?

Step by step solution

01

Understanding Hypotheses

In the context of a mammogram test, the null hypothesis ( H_0) is that the patient does not have the disease, meaning they do not have breast cancer. Conversely, if we reject  H_0, we are concluding that the patient does have the disease (breast cancer).

02

Explaining Type I Error

A Type I error, in this scenario, occurs when we incorrectly reject the null hypothesis ( H_0) when it is actually true. This means that the test indicates breast cancer is present when, in fact, it is not (a false positive result).

03

Discussing Type II Error

A Type II error happens when we fail to reject  H_0 when it is false; in other words, the test does not detect breast cancer when it is actually present (a false negative result). The consequences are severe, as a woman with undetected breast cancer might not receive necessary treatment in time.

04

Balancing Type I and Type II Errors

To decrease the chance of a Type I error (false positive), a radiologist may require stronger evidence of breast cancer before diagnosing it as positive. However, this increased threshold can result in a higher chance of a Type II error, meaning that actual cases of breast cancer could be missed (false negatives). This is a trade-off between increased specificity and reduced sensitivity of the test.

Unlock Step-by-Step Solutions & Ace Your Exams!

• Full Textbook Solutions

  Get detailed explanations and key concepts

• Unlimited Al creation

  Al flashcards, explanations, exams and more...

• Ads-free access

  To over 500 millions flashcards

• Money-back guarantee

  We refund you if you fail your exam.

Over 30 million students worldwide already upgrade their learning with 91Ó°ÊÓ!

Key Concepts

These are the key concepts you need to understand to accurately answer the question.

Type I Error

In medical diagnostic testing, a Type I error occurs when the test indicates a positive result for a disease that is not present—this is also known as a "false positive." Imagine taking a mammogram to check for breast cancer. You don't actually have the disease, but the test says you do. It's a classic Type I error.
This type of mistake usually results from rejecting the null hypothesis when it is true, meaning the medical test is incorrectly showing a disease presence. It's crucial to avoid Type I errors, as they can lead to unnecessary stress, anxiety, and potentially harmful treatments for patients who are actually disease-free.

Type II Error

A Type II error, on the other hand, occurs when a test fails to detect a disease that is present. This is referred to as a "false negative." Let's say you have breast cancer, but the mammogram results show that you don't. This can be devastating, as you might believe you're healthy when you're not.
The implications of Type II errors are severe because they can delay the treatment that is urgently needed. It happens when the null hypothesis is not rejected despite being false. In medical contexts, minimizing Type II error is vital to ensure that diseases are detected early and treated promptly.

Null Hypothesis

In medical testing, and in the context of hypothesis testing, the null hypothesis ( H_0) is an assumption that there is no effect or no disease. When using a diagnostic test such as a mammogram, the null hypothesis presumes the patient does not have breast cancer.
The null hypothesis serves as a baseline from which medical professionals can decide whether to continue with further testing or treatment. If evidence strongly contradicts this assumption, like a positive test in a reliable diagnostic tool, we reject the null hypothesis in favor of the alternative hypothesis.

False Positive

False positives are results indicating that someone has a disease when they actually do not. This is often the result of a Type I error. In medical diagnostic terms, it falsely alarms patients about a disease like breast cancer when the disease is not present.
This error can lead to increased anxiety and possibly harmful interventions like surgery or medication. Laboratories and medical facilities strive to minimize false positives by improving the precision of tests to ensure that only people with substantial evidence of a disease are given a positive result.

False Negative

A false negative occurs when a test fails to signal the presence of a disease that is indeed present, often due to a Type II error. For example, if a mammogram inaccurately reports no presence of breast cancer while the disease exists, it can lead to significant health repercussions.
False negatives can delay critical interventions and treatments, prolong the disease's progression, and potentially decrease the patient's prognosis. It is important to have a balanced diagnostic process that adequately detects true disease presence while minimizing incorrect negative calls.